Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

Published:2020-07-25 Issue:4 Volume:71 Page:508-515
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Salvador-Martín Sara,Bossacoma Ferrán,Pujol-Muncunill Gemma,Navas-López Víctor Manuel,Gallego-Fernández Carmen,Viada Javier,Muñoz-Codoceo Rosana,Magallares Lorena,Martínez-Ojinaga Eva,Moreno-Álvarez Ana,Solar-Boga Alfonso,Segarra Oscar,Clemente Susana,Rodriguez-Martinez Alejandro,Alvarez-Vayo Concepción,Loverdos Inés,Merino-Bohórquez Vicente,Balboa-Vega María J.,Blanca-García José A.,Fobelo María J.,Millán-Jiménez Antonio,García-Romero Ruth,Sanchez Cesar,Tolín Mar,Caldas Rafael Gonzalez de,Eizaguirre Francisco J.,Sánchez-Hernandez José G.,Torres-Peral Ricardo,Aznal Elena,García-González Xandra,Sanjurjo-Sáez María,López-Fernández Luis A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference52 articles.

1. Inflammatory bowel disease;Podolsky;N Engl J Med,2002

2. Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations;Kim;Gastroenterology,2004

3. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes;Yu;Semin Pediatr Surg,2017

4. Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT Registry;Martin-de-Carpi;Inflamm Bowel Dis,2013

5. Phenotypic and genotypic characterisation of inflammatory bowel disease presenting before the age of 2 years;Kammermeier;J Crohns Colitis,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2024-05-26

2. Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review;International Journal of Molecular Sciences;2024-03-27

3. The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model;Pediatric Drugs;2024-03-20

4. Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children;Pharmacological Research;2023-10

5. Association of the TNFRSF1B rs1061622 variant with nonresponse to infliximab in ulcerative colitis;2023-09-27